Hypercalcemic crisis (Q72376497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

review article

1 reference

title

Hypercalcemic crisis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

G W Edelson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Kleerekoper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

79-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

Management of acute hypercalcemia

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Parathyroid hormone-related peptide in sickness and in health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Lymphoma, hypercalcemia, and serum calcitriol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Acute severe hypercalcemia in a la Münchausen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparative study of available medical therapy for hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Clinical Review 9: Management of asymptomatic hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Management of disorders of calcium homoeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Intravenous etidronate in the management of malignant hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930085-2

10.1016/S0025-7125(16)30085-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7808096%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference